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Background: The primary stability of cancellous screw is difﬁcult to obtain in bone of compromised quality and
failure of screw ﬁxation is common. To overcome this problem, it is proposed to locally deliver bisphosphonate
from the screw. An in vivo validation of the increase in ﬁxation of the cancellous screw is then needed in
compromised bone.
Methods: In this study, we used an overdrilling procedure, which enables consistent modeling of reduced screw
stability comparable to compromised cancellous bone. Forty eight adult NZW rabbits were used in this study and
all animals underwent bilateral femur implantation. One leg was implanted with the screw containing the
bisphosphonate (biocoated group) while the other was used as control (control group) with the screw only.
Mechanical testing and micro-CT imaging were used to assess the effect of local drug delivery of Zoledronate on
screws ﬁxation at 5 time points.
Findings: At the early time points (1, 5, and 10 days), no signiﬁcant difference could be seen between the
biocoated and control groups. At 6 weeks, the bone volume fraction was signiﬁcantly higher in the trabecular
region of the biocoated group. However, this increase did not have a signiﬁcant effect on the pull-out force. At
the last time point, 11 weeks, both the bone volume fraction and the pull-out force were signiﬁcantly higher in
the biocoated group.
Interpretation: The results of this study suggest that, in compromised bone, local delivery of bisphosphonate
enhances the stability of bone screws.
© 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Initial ﬁxation of screws in osteoporotic bone is frequently difﬁcult
to obtain (Seebeck et al., 2005). Moreover, during the early healing
phase, micromotions between implant and bone can activate an
osteoclastic response, which may increase further bone resorption
(Stadelmann et al., 2008) and consequently may lead to unstable
ﬁxation. Indeed, there is a clinically observed high rate of failure of
screw ﬁxation in osteoporotic patients (Bjorkenheim et al., 2004).
Bisphosphonates, predominantly amino-bisphosphonates such as
zoledronate are known to be highly potent drugs affecting bone
metabolism by affecting osteoclast activity through the inhibition of
the enzyme farnesyl pyrophosphate synthase (Russell et al., 2008).
Thus one might hypothesize that the association between an
orthopedic implant and a bisphosphonate could decrease the peri-
implant bone resorption, and hence increasing the stability of the
implant. Indeed, orthopedic implants designed to locally deliver
bisphosphonates have been demonstrated to increase their ﬁxation in
animal studies (Wermelin et al., 2008a), even in osteoporotic bone
(Peter et al., 2006) or very recently for dental implant in human
(Abtahi et al., 2010). Several reviews have been recently published
supporting the idea that a general positive effect is observed on bone
volume fraction and implant ﬁxation when an implant is used as local
bisphosphonate delivery (Aspenberg, 2009; Pioletti et al., 2008). In
particular, increase in bone volume fraction and pull-out force was
observed as early as 2 to 3 weeks in rats after insertion of the implant
coated with bisphosphonate (Peter et al., 2005; Wermelin et al.,
2008b). The increase in implant ﬁxation was correlated to the amount
of bone formed at the close vicinity of the implant (Peter et al., 2006).
However, as observed by Aspenberg, the local presence of the
bisphosphonate is not responsible for new bone formation, but rather
for the preservation of the initial osteoid formed around the implant
which can then be used as scaffold for further bone formation
(Aspenberg, 2009) and ﬁnally leading to an increase implant ﬁxation.
The coating of screw with bisphosphonate in osteoporotic bone
would then be an advantageous solution and could help in the screw
ﬁxation. However, available animal models intended to model human
osteoporosis suffer from certain drawbacks (Turner, 2001). Even after
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combining different strategies such as ovariectomy, low-calcium diet
and steroid application, in sheep for example, bone densities have
been demonstrated to be signiﬁcantly higher (≥30%) than healthy
human bone equivalents (Augat et al., 2003). Currently, osteoporotic
animal models failed to reach bone density levels being obvious in
human osteoporotic bone. In parallel, osteoporotic bone is also
characterized by a reduction of trabeculi number as well as reduced
thickness (Parﬁtt et al., 1983). The impaired trabecular architecture
results in smaller contact area between implant and bone, which in
the case of orthopedic screws, is similar to an increase in gap between
the core of the screw and the bone. It has then been proposed to use an
overdrilling defect to create oversized defect with a low implant/bone
contact area. The intention of this model was to create a reduced pull-
out force being comparable to data achieved in osteopenic or
osteoporotic bone (Hoshikawa et al., 2003).
In this study we hypothesize that local delivery of bisphosphonate
on screw results in enhanced ﬁxation in compromised cancellous
bone. For this purpose, an overdrilling procedure was used, which
enables consistent modelling of reduced screw stability comparable to
compromised cancellous bone.
2. Methods
This study was conducted in accordance with the provisions of the
FDA Good Laboratory Practice (21 CFR, Part 58, April 01, 2006) and the
OECD Good Laboratory Practices, (ENV/CM/CHEM (98)11, 1997). The
study plan was approved by the Biomatech Ethical Committee on
November 19, 2009.
2.1. Animals
Forty eight adult 4 month old NZW rabbits were randomly divided
into 4 groups of n=10 each and one reserve group of n=8.
Husbandry conditions were in conformance to the European re-
quirements (Directive EEC/86/609). The rabbits were individually
housed. Humidity was maintained higher than 30% of relative
humidity and temperature was between 17 °C and 21 °C. The artiﬁcial
light cycle was controlled using an automatic timer (12 h of light, 12 h
of dark). Municipal water was delivered ad libitum. Rabbit granulated
high ﬁber diet 115 (SAFE, Augy, France) was provided daily, 200 g per
day. All rabbits underwent bilateral femur implantation. In a paired
approach, each medial distal femoral condyle received one 4.0 mm Ø
cancellous bone screw, either coated with zoledronate-loaded
ﬁbrinogen (hereafter termed biocoated screws) or non-coated
(control screws). The implantation site as well as the application of
biocoated and control screws was randomized. As no animal
replacement was needed during the observation period, the reserve
animals were used to create another long-term follow-up (11 weeks).
Samples were analyzed by means of micro-CT, biomechanical testing
and histology.
2.2. Implants
For implantation, a standard 4.0 mm ∅ Titanium bone screw
(bone screw#604014, Stryker, Selzach, Switzerland), intended for use
in cancellous bone was used. The core diameter of the screw was
1.9 mm and the corresponding standard drill diameter 2.5 mm. The
overall screw length of 14 mm was deﬁned as the intended insertion
depth of 10 mm plus a sufﬁcient distance of the screw head above the
bone surface to enable clamping the screw head for the biomechanical
testing. Sixty bone screws were provided to AddBIO AB (Linköping,
Sweden) for biocoating (biocoated group) (proprietary name FibMat).
Another 60 bone screws served as controls (control group).
2.3. Biocoating with bisphosphonate
Bisphosphonate (synthetic zoledronic acid, REF ALX-430-153-
M025) was provided by the chemical supplier Alexis (Lausen,
Switzerland). Screws were coated with a ﬁbrinogen multilayer
incorporating an amount of 150 ng/cm2 of zoledronic acid (Tengvall
et al., 2004). This loadingdose could be considered comparable to a local
concentration of 500 nM.As a comparison, thehalfmaximum inhibitory
concentration (IC50) for zoledronate is about 5 nM. After single
packaging in peel-pouches, all screws were sterilized by performing
γ-irradiation at 17–25 kGy (Leoni, Switzerland).
2.4. Surgical procedure
In a standardized procedure, the femoral condyle was addressed
for implantation. Surgical as well as implantation procedure followed
a previously published protocol (Hoshikawa et al., 2003). The surgical
approach was done bilaterally by performing one implantation per
site. The “paired” design allowed comparison between biocoated and
control groups and reduced variation. A longitudinal incision was
performed demonstrating the medial aspect of each distal femoral
condyle. The entry point for drilling was localized by using the
insertion point of the medial contralateral ligament as a landmark.
Going 5 mm proximal, the entry point for drilling was set. Direction of
drilling was maintained perpendicular to the slightly curved bone
surface. Any perforation of the intracondylar groove was avoided.
Drilling was initiated by introducing a 1.4 mm ∅ Guide Wire. To
avoid perforation of the opposite cortex, the Guide Wire was labeled
with a laser marker at a 10 mm insertion depth. Allowing appropriate
allocation of the defect, opening to ﬁnal drill size was performed using
a cannulated 3.7 mm ∅ drill. The choice of a 3.7 mm overdrill
diameter was based on a preliminary study made in cadaver knee
rabbit showing that this diameter effectively decreased the pull-out
force (data not shown). The customized drills were equipped with a
depth stop at 10 mm. To reduce thermal impact of drilling and remove
bone debris, during and after power-driven drilling, ﬂushing with
saline solution was performed. The screw was ﬁrst inserted by hand,
then turned down to ﬁnal position using the screwdriver. The hind
limb wound was closed by subcutaneous and cutaneous suturings. A
systemic antibiotic and pain management was applied. Anteroposter-
ior (AP) and mediolateral (ML) radiographs were taken to document
screw positioning. The rabbits were monitored until complete
recovery from the anesthesia and then returned to their cages.
2.5. Sample preparation/data analysis
All animals were kept under observation for the proposed time
points. The animals were observed daily for general health and in
particular for any visible sign of screw migration, wound infection or
major signs of pain. At termination, the animals were euthanized
under anesthesia (intramuscular injection of Zoletil®, Virbac, France)
by intravenous pentobarbital injection (Dolethal®, Vetoquinol,
France). At 1, 5 and 10 days as well as at 6 and 11 weeks, animals
were sacriﬁced and the femoral condyles were harvested for micro-CT
examination and biomechanical testing. In addition at 6 weeks,
histological analysis was performed.
2.6. Macroscopical evaluation
At euthanasia, the region of the initial implantation was carefully
exposed. Gross photography of the implant site was taken (Fig. 1).
Prior to all destructive investigations, radiological analysis (AP and
MD) was used to evaluate the performance up to 11 weeks.
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2.7. Micro-CT imaging
The screw head was clamped in a specially designed screw holding
sleeve to ensure the alignment of the screwwith the scanning axis. The
holding sleevewas then placed in the polystyrene support of the in-vivo
μCT Scanner 1076 (SkyScan, Belgium). Samples were scanned at
100 kV/100 mA source voltage/current, with a 1 mm aluminum ﬁlter.
Thepixel size (resolution), rotation step, andexposure timewere18 μm,
0.6° over 360°, and 400 ms, respectively. The dataset was reconstructed
with NRecon software (SkyScan, Belgium). Moderate beam hardening
was applied in the reconstruction process. The μCT analysis was done
with dedicated software CTAN (SkyScan, Belgium). The Hounsﬁeld Unit
(HU) and bonemineral density (BMD) calibrations were ﬁrst applied to
the dataset. Two phantoms of calcium density 0.25 g/mm3 and 0.75 g/
mm3 of 8 mmdiameter (Gloor Instruments, Switzerland)were scanned
in a 10 ml Falcon tube ﬁlled with puriﬁed water using the scanning
parameters described previously. Manufacturer's HU and BMD calibra-
tion procedures were then followed. The region of interest (ROI) was
chosen as a sleeve around the screw with 0.5 mm of thickness (Fig. 2).
The cortical bone at the entrance point of screw was excluded.
Afterwards, the bone volume (BV), tissue volume (TV), and BMD of
bone tissueweremeasured for eachdataset. Bonevolume fraction (BVF)
is deﬁned as the percentage of bone volume over tissue volume (%BV/
TV).
2.8. Biomechanical analysis
Implant sites were prepared for biomechanical analysis by
wrapping them in isotonic drained (PBS) patches, packed into labeled
tubes and, stored in a cooled environment (4 °C). For each time point,
12 samples (6× biocoated and 6× control) were evaluated. The
specimens were embedded in Neukadur cement (Troller, Switzer-
land) keeping the screw axis perpendicular to the mold, making sure
the later pull-out orientation was always consistent. The screw head
was then gripped and subjected to pull-out (Instron, USA) until bone
failure. The maximum pull-out force was measured for each sample,
accordingly.
2.9. Histology
Samples were collected at 6 weeks after implantation (4× biocoated
and 4× control, one section was prepared out of each sample and
evaluated). The implant sites were removed as small blocks by sawing
perpendicular to the screw canals. Subsequently, the blocks were ﬁxed
in 4% paraformaldehyde for up to 1 week, dehydrated in a series of
increasing concentrations of ethanol and embedded in polymethyl-
methacrylate according to standard histological techniques. Two
longitudinal sections per specimen were obtained by micro-cutting
and grinding procedures (Donath and Breuner, 1982). The ground
sections (20 to 30 μm) were stained with modiﬁed paragon for
qualitative and semi-quantitative analyses.
2.10. Statistical analysis
All statistical analysis was performed in MATLAB (Mathworks).
Group comparisons were done using two-way ANOVA. As the control
screws were paired with the biocoated screws in each rabbit, we
employed paired t-test for pair-wise comparison. Biomechanical
differences were considered signiﬁcant if Pb0.05.
3. Results
3.1. Macroscopic evaluation
Transverse slices of samples from all time points are shown in
Fig. 3. As the holes were over-drilled prior to the insertion of the
screws, it was expected that there would be little contact between
screw and bone at earlier time points (1 day, 5 days, and 10 days).
Nevertheless, in a few samples some bone was observed in the
internal thread (Fig. 3a). This might be the residue from the drilling
process. Also notice that in some cases, the screw is not concentric
with the hole (Fig. 3b). These two factors may play an important role
in the variation between samples within the same time point. At
6 weeks, bone formation around the walls of the internal thread
(Fig. 3d and i) is clearly observed, and at 11 weeks, bone has covered
the internal thread completely (Fig. 3e and j). Also note the formation
of callus around the external part of some of the screws at 11 weeks
(Fig. 3e).
3.2. Micro-CT imaging
BVF was measured in a deﬁned ROI around the screw. During the
pull-out tests it was observed that the amount of bone tissue taken out
with the screw increases over time. This observation was conﬁrmed by
Fig. 1. Implantation site after (left) 1 day (control) and (right) 11 weeks (biocoated).
Fig. 2. (Left) X-Ray photo of screw embedded in distal femur. Red lines indicate the area
of interest. (Right) Illustration showing the ROI around the threads. The dash dot line
represents the axis of the screw.
Fig. 3. Transverse slices of distal femur through the screw for a typical rabbit at each
time point. (a)–(e) Control group, and (f)–(j) biocoated group, at 1 day, 5 days, 10 days,
6 weeks, and 11 weeks, respectively.
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measuring BVF over time, which signiﬁcantly increases (Pb0.01)
(Fig. 4a). The BD in the biocoated group is signiﬁcantly higher at 6 and
11 weeks compared to the control group (Pb0.01 and P=0.015,
respectively), but not at the early time points. It was noted that BMD
of bone tissue in ROI signiﬁcantly increased in time in each group, but
there was no difference between the two groups.
3.3. Biomechanical analysis
The biocoated group had a signiﬁcantly higher pull-out force at
11 weeks than the control group (P=0.05) but not at prior time
points (Fig. 4b). The correlation between BD and maximum pull-out
force was 0.95.
3.4. Histology
Analyzing control and biocoated groups six weeks after implan-
tation, a consistent osseous reaction was noticed. Bone ingrowth
showing signs of remodeling was observed within the screw threads
of both groups. No residue of ﬁbrin, blood clots, ﬁbroblastic tissue or
bone debris but a differentiated adipocytic bone marrow could be
detected further substantiating the ongoing remodeling process as
shown for a biocoated sample in Fig. 5a and b. The cartilaginous tissue
associated with ossiﬁcation areas was fully ossiﬁed with formation of
a young cancellous bone (Fig. 5c and d). At 6 weeks, histological
sections of the biocoated group demonstrated extensive bone
formation covering the screw thread almost completely.
4. Discussion
The objective of this study was to evaluate the effect of local
bisphosphonate application on screw ﬁxation in compromised
cancellous bone. To reduce screw stability comparable to compro-
mised cancellous bone, an overdrilling procedure was conducted.
Three early time points (1 day, 5 days, and 10 days) and two late time
points (6 and 11 weeks) were chosen for the evaluation. This study
showed that at the last time point, both the bone volume fraction and
the pull-out force were signiﬁcantly higher in the biocoated group.
Thus our hypothesis was veriﬁed. The local delivery of bisphos-
phonate on screw results in enhanced ﬁxation in compromised
cancellous bone.
Developing new strategies for achieving stable fracture ﬁxation in
low-density cancellous bone requires establishing appropriate preclin-
ical in vivomodels. A limitednumberof optionswere available. Sheepare
one of thedominantorthopedic animalmodels andhave been frequently
used to investigate the impact of compromised bone on implant stability
and performance. Osteopenic sheep or even goat demonstrated a
signiﬁcant reduction in bone mineral density and trabecular micro
architecture as compared to healthy ones (Schorlemmer et al., 2003).
Reduction of bone mineral density reaches levels of 200–300 mg/cm3.
Although bone mineral density is signiﬁcantly reduced, levels, seen in
human osteoporotic patients (50–150 mg/cm3) are not reached (Riggs
et al., 2004). Another option, intended to simulate insufﬁcient bonemass
is the technique of overdrilling used in the present study with rabbit.
Originally this technique was developed to demonstrate the beneﬁcial
effects of bone augmentation with bone cements. Hoshikawa et al.
showed that overdrilling screw sites allowed demonstration of the
effects of screw augmentation even in bone being more dense than
comparable human bone structure sites (Hoshikawa et al., 2003). In
recent literature, mechanical testing in bone with a low bone mineral
density either induced by osteoporosis or by overdrilling is claimed to
result in a similar effect (Grardel et al., 1994; Castaneda et al., 2008). The
model mimics a low bone density by providing less bone/implant
contact. The overdrilling model has certain limitations. However, the
overdrilling model does change the trabecular density as well as the
Fig. 4. Box plot of the paired difference between coated and control group (left) bone
volume fraction, and (right) pull-out force, at different time points (*: P-valueb0.05,
**: P-valueb0.01).
Fig. 5. At 6 weeks for a biocoated sample, bone formation around the walls of the
internal thread started to cover the internal thread almost completely. (a) Screw tip is
completely “coated” by new bone and (b) screw geometry almost completely covered
by newly formed bone. (c) Formation of trabecular like bone in the empty space around
the screw. (d) The cartilaginous tissue (marked by *) was fully ossiﬁed with formation
of young bone (marked by **) (for scale, the distance between two thread is 1.75 mm).
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trabecular thickness, both being characteristic critical parameters in
osteoporotic human bone (Parﬁtt et al., 1983).
Based on the current literature (Peter et al., 2005; Wermelin et al.,
2008a), we hypothesized that local delivery of bisphosphonate
enhances the ﬁxation of the screw in a compromised cancellous site.
This hypothesis was veriﬁed although only at the latest time point. The
present study provided no evidence that local drug application at the
implantation site had a signiﬁcant impact on osteoclastic activity. The
histological evaluation of biocoated and control implant sites revealed
nosigniﬁcantdifferences in the resorptionpattern. Thismight be related
to the low dose application of zoledronate or also to the increase in
diffusion path of the drug generated by the overdrilling procedure. The
increase in diffusion path of the drug could explain that the increase in
ﬁxation was only observed at late time point.
It is noteworthy to mention the possible sources of variation in this
experiment. In the CT slices, it was observed that screw orientation was
not always consistent. This might be due to the overdrilling procedure,
allowing a certain freedom of screw positioning during insertion. In
addition, at late time points, sporadic bone formation at the exterior of
the holes was obvious in both groups, impacting the outcome of the
pull-out testing.
Conclusion
The results of this study suggest that local delivery of bispho-
sphonate enhances the stability of bone screws in the rabbit model.
However, further dose response evaluations will be needed for
analyzing the effects of different local drug concentrations released
from biocoatings on metal implants.
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